FUJIFILM Biotechnologies held a ribbon‑cutting ceremony to mark the opening of its new, 2,000‑square‑meter (m2) quality control (QC) laboratory at its Hillerød, Denmark, commercial‑scale manufacturing site.
Ardena, a CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, announces that its new GLP bioanalytical laboratory in Somerset, New Jersey, is now operational and supporting client studies.
Integrion Automation, a Cornerstone Corporation operating company, has announced that Joe Gemma will retire from his role as chief executive officer and transition to serve as strategic advisor to the company.
Bioengineering announced after the Board of Directors meeting on April 13th the appointment of Mr. Jiang Pei as its new Chief Executive Officer (CEO), effective April 13, 2026.
Arterex has announced the expansion of its facility in Mansfield, Massachusetts, USA, which specialises in the development and manufacturing of FDA Class 2 and Class 3 electromechanical devices (EMDs) and implantable devices for OEMS.
ROIS, the CDMO arm of ROVI has announced closing the acquisition of an injectable drug product manufacturing and packaging site in Phoenix, Arizona (USA) from Bristol Myers Squibb.
Lupin has announced the completion of its acquisition of VISUfarma, a European specialty pharmaceutical company focused on ophthalmology, from GHO Capital Partners LLP (GHO).
Adragos Pharma, a global contract development and manufacturing organisation (CDMO), has announced that it completed the acquisition of a commercial-scale sterile fill-finish facility in Maisons-Alfort, France, from Sanofi.
Samsung Biologics has announced the completion of its acquisition of a manufacturing facility in Rockville, Maryland from GSK, establishing the company’s first manufacturing presence in the United States.
Bracco Imaging announced an upgrade of its manufacturing site in Geneva to support clinical-grade GMP manufacturing of its cell therapy-enabling microbubble technology, building on its previously announced Investments in the site since 2019.